BDX vs MNOV · P/E 34, rev $21.84B vs rev $645.4K
Becton Dickinson and Company (BDX) versus MediciNova Inc (MNOV) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported MNOV revenue for 2026-06-30 was $645.4K. Net income was -$4.9M. MNOV currently screens at market cap $66.0M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. MNOV currently screens at market cap $66.0M.
Not investment advice. Open the BDX and MNOV stock pages for the full models.
Not investment advice.